Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.62 -2.21 (-2.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) EBT Margin (2011 - 2026)

Updated

Ani Pharmaceuticals (ANIP) recorded EBT Margin of 13.94% in Q2 2026, up 8.96 percentage points from 4.98% a year earlier but down 2.99 percentage points from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) EBT Margin (2011 - 2026) Analysis & Trends

On a TTM basis, Ani Pharmaceuticals' EBT Margin came in at 14.57% as of Jun 30, 2026, up 16.55 percentage points year-over-year; for FY2025, it came in at 10.84%, up 14.46 percentage points from FY2024.

  • Annual EBT Margin has a five-year change of +23.30 percentage points (FY2020 to FY2025).
  • Across earlier years, EBT Margin came in at -3.62% in FY2024 (-7.70 pp), 4.08% in FY2023 (+23.89 pp), -19.81% in FY2022 (+6.13 pp) and -25.94% in FY2021 (-13.48 pp).
  • Quarterly EBT Margin has ranged from -50.64% in Q4 2021 to 18.43% in Q1 2024 over the past five years.
  • On a year-over-year basis, EBT Margin has increased for five consecutive quarters, with an average year-over-year change of +4.03 percentage points over the last eight quarters.
  • Peak year-over-year performance for EBT Margin in the last five years was a gain of 44.56 percentage points in Q4 2022, against a drop of 46.51 percentage points in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at 16.94% (Q1 2026), 12.74% (Q4 2025) and 14.84% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Ani Pharmaceuticals 1.78 Bn 565.34 Mn 165.89 Mn 13.94%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.94%
Mar 31, 2026 16.94%
Dec 31, 2025 12.74%
Sep 30, 2025 14.84%
Jun 30, 2025 4.98%
Mar 31, 2025 10.14%
Dec 31, 2024 -7.22%
Sep 30, 2024 -21.23%
Jun 30, 2024 -1.66%
Mar 31, 2024 18.43%
Dec 31, 2023 0.72%
Sep 30, 2023 8.73%
Jun 30, 2023 4.50%
Mar 31, 2023 2.06%
Dec 31, 2022 -6.08%
Sep 30, 2022 -14.58%
Jun 30, 2022 -25.48%
Mar 31, 2022 -40.17%
Dec 31, 2021 -50.64%
Sep 30, 2021 -13.70%
API Access

Ani Pharmaceuticals EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ANIP&period=max&api_key=YOUR_API_KEY